The U.S. Ending the HIV Epidemic (EHE) Initiative: What You Need to Know
This explainer provides an overview of the federal “Ending the HIV Epidemic” initiative and explores issues that might mitigate or facilitate its success.
View the Latest: HIV/AIDS in U.S.
Filter
-
-
Delivering HIV Care and Prevention in the COVID Era: A National Survey of Ryan White Providers
Issue BriefThis survey of Ryan White-funded providers examines the significant challenges posed by the COVID-19 pandemic on the people with HIV and the systems that serve them.
-
Potential Health Policy Administrative Actions Under President Biden
Issue BriefThis brief outlines the potential health policy actions that President Biden could take using executive authority, based on campaign pledges, and actions that would reverse or modify regulations or guidance issued by the Trump Administration.
-
Insurance Coverage and Viral Suppression Among People with HIV, 2018
Issue BriefThis analysis examines insurance coverage among people with HIV in 2018, and the relationship between insurance coverage, viral suppression, and support from the Ryan White Program.
-
The Trump Administration’s Final Rule on Section 1557 Non-Discrimination Regulations Under the ACA and Current Status
Issue BriefSection 1557 of the Affordable Care Act prohibits discrimination based on race, color, national origin, sex, age, and disability in health programs and activities receiving federal funds. Here are the significant ways HHS's final rule would narrow the scope of this regulation.
-
Insurance Coverage and Viral Suppression Among People with HIV in the United States, 2015-2018
FeatureHealth insurance coverage and access to care improve health outcomes, including viral suppression, for people with HIV in the United States. Prior research has demonstrated that implementation of the Affordable Care Act (ACA) in 2014 increased coverage among people with HIV and that certain forms of coverage are positively correlated with sustained viral suppression. We provide a 2018 update, the latest nationally representative data in this area, as well as trends over time.
-
Greater Than AIDS, with Support from Walgreens and Orasure Technologies, to Provide 10,000 Free In-Home HIV Tests to Community Partners
News ReleaseWith in-person health services limited due to COVID-19, Greater Than AIDS, a public information initiative of KFF, and Walgreens announced a new program to provide 10,000 OraQuick® In-Home HIV Test kits to support expanded testing options in high-need areas.
-
State Medicaid Management of Prescription Drugs for HIV Treatment and Prevention
Issue BriefThis data note, primarily based on a survey of state Medicaid pharmacies, reviews cost-containment policies and protections as they relate to antiretrovirals for treatment and prevention of HIV.
-
What We Can Learn from HIV in Communicating about COVID-19
Policy WatchAs we navigate how to communicate about COVID-19 and the urgent public health issues it brings, there is much that can be learned in looking at HIV messaging and how it has evolved. This blog discusses some of our observations from KFF’s more than two decades of experience running large-scale public information campaigns about HIV and other communicable diseases that have bearing in this new environment.
-
Managing HIV During COVID-19: Working to End One Epidemic While Confronting Another
Policy WatchAs the COVID-19 outbreak continues to grow in the United States, it threatens efforts to address existing health challenges, including the HIV/AIDS epidemic. This blog piece explores whether efforts to “end the HIV epidemic” can be sustained while confronting COVID-19, particularly as the very systems and workforce needed to address HIV are being stretched thin to confront the new crisis.